Stay Ahead of Compliance with Monthly Citation Updates


In your State Survey window and need a snapshot of your risks?

Survey Preparedness Report

One Time Fee
$79
  • Last 12 months of citation data in one tailored report
  • Pinpoint the tags driving penalties in facilities like yours
  • Jump to regulations and pathways used by surveyors
  • Access to your report within 2 hours of purchase
  • Easily share it with your team - no registration needed
Get Your Report Now →

Monthly citation updates straight to your inbox for ongoing preparation?

Monthly Citation Reports

$18.90 per month
  • Latest citation updates delivered monthly to your email
  • Citations organized by compliance areas
  • Shared automatically with your team, by area
  • Customizable for your state(s) of interest
  • Direct links to CMS documentation relevant parts
Learn more →

Save Hours of Work with AI-Powered Plan of Correction Writer


One-Time Fee

$49 per Plan of Correction
Volume discounts available – save up to 20%
  • Quickly search for approved POC from other facilities
  • Instant access
  • Intuitive interface
  • No recurring fees
  • Save hours of work
F0757
D

Failure to Monitor for Adverse Reactions to High-Risk Medication

Clintonville, Wisconsin Survey Completed on 04-23-2025

Penalty

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Summary

The facility failed to monitor for adverse reactions or side effects of a high-risk medication, gabapentin, for one resident. The resident had a history of hemiplegia and hemiparesis following a stroke, long-term use of anticoagulants, and was cognitively intact with a BIMS score of 15. The resident was prescribed gabapentin 400 mg to be taken three times daily for neuropathic pain and restless leg syndrome. Despite the known potential side effects of gabapentin, including serious reactions, the resident's medical record did not contain any documentation of monitoring for adverse reactions or side effects. This lack of monitoring was confirmed by the DON upon review of the resident's medical record during the survey.

An unhandled error has occurred. Reload 🗙